NDC 55150-217 – Atracurium Besylate
Atracurium Besylate 100 mg/10mL · Injection, Solution · Intravenous
Product NDC55150-217
Product details
- Brand name
- Atracurium Besylate
- Generic name
- Atracurium Besylate
- Labeler
- AuroMedics Pharma LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA206011
- Marketed since
- April 8, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nondepolarizing Neuromuscular Blocker
Active ingredients
- Atracurium Besylate 100 mg/10mL
Uses, dosage, side effects and warnings for Atracurium Besylate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55150-217-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (55150-217-10) / 10 mL in 1 VIAL, MULTI-DOSE | Apr 8, 2015 |
Other Atracurium Besylate products
- 55150-216 Atracurium Besylate 50 mg/5mL · Injection, Solution · AuroMedics Pharma LLC
- 0409-1105 Atracurium Besylate 10 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-1109 Atracurium Besylate 10 mg/mL · Injection, Solution · Hospira, Inc.
- 71288-701 Atracurium Besylate 10 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-702 Atracurium Besylate 10 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.